| mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-05 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
8e-05 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
0.0001 |